Cargando…

The Relationship Between <sup>99m</sup>Tc-Pertechnetate Hand Perfusion Scintigraphy and Nailfold Capillaroscopy in Systemic Sclerosis Patients: A Pilot Study

OBJECTIVES: This study aims to assess the possible relationship between (99m)Tc-pertechnetate hand perfusion scintigraphy (HPS) and nailfold capillaroscopy (NC) in systemic sclerosis (SSc) patients. PATIENTS AND METHODS: The study group consisted of 25 SSc patients (6 males; 19 females; mean age 54....

Descripción completa

Detalles Bibliográficos
Autores principales: PAVLOV-DOLIJANOVIC, Slavica, PETROVIC, Nebojsa, VUJASINOVIC STUPAR, Nada, DAMJANOV, Nemanja, RADUNOVIC, Goran, BABIC, Dragan, SOBIC-SARANOVIC, Dragana, ARTIKO, Vera
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Turkish League Against Rheumatism 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7788645/
https://www.ncbi.nlm.nih.gov/pubmed/33458654
http://dx.doi.org/10.46497/ArchRheumatol.2020.7730
_version_ 1783633071626518528
author PAVLOV-DOLIJANOVIC, Slavica
PETROVIC, Nebojsa
VUJASINOVIC STUPAR, Nada
DAMJANOV, Nemanja
RADUNOVIC, Goran
BABIC, Dragan
SOBIC-SARANOVIC, Dragana
ARTIKO, Vera
author_facet PAVLOV-DOLIJANOVIC, Slavica
PETROVIC, Nebojsa
VUJASINOVIC STUPAR, Nada
DAMJANOV, Nemanja
RADUNOVIC, Goran
BABIC, Dragan
SOBIC-SARANOVIC, Dragana
ARTIKO, Vera
author_sort PAVLOV-DOLIJANOVIC, Slavica
collection PubMed
description OBJECTIVES: This study aims to assess the possible relationship between (99m)Tc-pertechnetate hand perfusion scintigraphy (HPS) and nailfold capillaroscopy (NC) in systemic sclerosis (SSc) patients. PATIENTS AND METHODS: The study group consisted of 25 SSc patients (6 males; 19 females; mean age 54.2±9.7 years; range, 32 to 67 years), 18 female patients with primary Raynaud's phenomenon (PRP) (mean age 47.1±9.5 years; range, 34 to 65 years) and 10 healthy individuals (3 males, 7 females; mean age 52.7±12.6 years; range, 37 to 73 years). NC and (99m)Tc-pertechnetate HPS were performed in all examinees. The capillaroscopic findings were classified as normal or scleroderma pattern ("early", "active", or "late"). The fingers-to-palm ratios were calculated for both blood flow (BF) and blood pool (BP) phases of the (99m)Tc-pertechnetate HPS. RESULTS: Systemic sclerosis patients showed a significantly lower BP ratio than PRP patients and healthy subjects (p=0.004). No statistically significant difference was observed between the SSc and PRP patients in respect to BF ratio. A gradual decrease of BF and BP with the severity of NC microangiopathy pattern ("early", "active" or "late") was found in SSc patients, while the differences were not statistically significant. Patients with diffuse SSc showed lower BF and higher BP than those with limited SSc, while these differences were without statistical significance. There was no significant correlation between BF or BP values and type of SSc (limited or diffuse) (p=0.77 versus p=0.54, respectively) as well as three microangiopathy patterns (p=0.22 versus p=0.54, respectively). CONCLUSION: (99m)Tc-pertechnetate HPS improves the evaluation of vascular damage in SSc patients. There is no direct relationship between NC and (99m)Tc-pertechnetate HPS; however, the two methods complement each other in the assessment of microcirculation in SSc.
format Online
Article
Text
id pubmed-7788645
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Turkish League Against Rheumatism
record_format MEDLINE/PubMed
spelling pubmed-77886452021-01-14 The Relationship Between <sup>99m</sup>Tc-Pertechnetate Hand Perfusion Scintigraphy and Nailfold Capillaroscopy in Systemic Sclerosis Patients: A Pilot Study PAVLOV-DOLIJANOVIC, Slavica PETROVIC, Nebojsa VUJASINOVIC STUPAR, Nada DAMJANOV, Nemanja RADUNOVIC, Goran BABIC, Dragan SOBIC-SARANOVIC, Dragana ARTIKO, Vera Arch Rheumatol Original Article OBJECTIVES: This study aims to assess the possible relationship between (99m)Tc-pertechnetate hand perfusion scintigraphy (HPS) and nailfold capillaroscopy (NC) in systemic sclerosis (SSc) patients. PATIENTS AND METHODS: The study group consisted of 25 SSc patients (6 males; 19 females; mean age 54.2±9.7 years; range, 32 to 67 years), 18 female patients with primary Raynaud's phenomenon (PRP) (mean age 47.1±9.5 years; range, 34 to 65 years) and 10 healthy individuals (3 males, 7 females; mean age 52.7±12.6 years; range, 37 to 73 years). NC and (99m)Tc-pertechnetate HPS were performed in all examinees. The capillaroscopic findings were classified as normal or scleroderma pattern ("early", "active", or "late"). The fingers-to-palm ratios were calculated for both blood flow (BF) and blood pool (BP) phases of the (99m)Tc-pertechnetate HPS. RESULTS: Systemic sclerosis patients showed a significantly lower BP ratio than PRP patients and healthy subjects (p=0.004). No statistically significant difference was observed between the SSc and PRP patients in respect to BF ratio. A gradual decrease of BF and BP with the severity of NC microangiopathy pattern ("early", "active" or "late") was found in SSc patients, while the differences were not statistically significant. Patients with diffuse SSc showed lower BF and higher BP than those with limited SSc, while these differences were without statistical significance. There was no significant correlation between BF or BP values and type of SSc (limited or diffuse) (p=0.77 versus p=0.54, respectively) as well as three microangiopathy patterns (p=0.22 versus p=0.54, respectively). CONCLUSION: (99m)Tc-pertechnetate HPS improves the evaluation of vascular damage in SSc patients. There is no direct relationship between NC and (99m)Tc-pertechnetate HPS; however, the two methods complement each other in the assessment of microcirculation in SSc. Turkish League Against Rheumatism 2020-02-07 /pmc/articles/PMC7788645/ /pubmed/33458654 http://dx.doi.org/10.46497/ArchRheumatol.2020.7730 Text en Copyright © 2020, Turkish League Against Rheumatism http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Original Article
PAVLOV-DOLIJANOVIC, Slavica
PETROVIC, Nebojsa
VUJASINOVIC STUPAR, Nada
DAMJANOV, Nemanja
RADUNOVIC, Goran
BABIC, Dragan
SOBIC-SARANOVIC, Dragana
ARTIKO, Vera
The Relationship Between <sup>99m</sup>Tc-Pertechnetate Hand Perfusion Scintigraphy and Nailfold Capillaroscopy in Systemic Sclerosis Patients: A Pilot Study
title The Relationship Between <sup>99m</sup>Tc-Pertechnetate Hand Perfusion Scintigraphy and Nailfold Capillaroscopy in Systemic Sclerosis Patients: A Pilot Study
title_full The Relationship Between <sup>99m</sup>Tc-Pertechnetate Hand Perfusion Scintigraphy and Nailfold Capillaroscopy in Systemic Sclerosis Patients: A Pilot Study
title_fullStr The Relationship Between <sup>99m</sup>Tc-Pertechnetate Hand Perfusion Scintigraphy and Nailfold Capillaroscopy in Systemic Sclerosis Patients: A Pilot Study
title_full_unstemmed The Relationship Between <sup>99m</sup>Tc-Pertechnetate Hand Perfusion Scintigraphy and Nailfold Capillaroscopy in Systemic Sclerosis Patients: A Pilot Study
title_short The Relationship Between <sup>99m</sup>Tc-Pertechnetate Hand Perfusion Scintigraphy and Nailfold Capillaroscopy in Systemic Sclerosis Patients: A Pilot Study
title_sort relationship between <sup>99m</sup>tc-pertechnetate hand perfusion scintigraphy and nailfold capillaroscopy in systemic sclerosis patients: a pilot study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7788645/
https://www.ncbi.nlm.nih.gov/pubmed/33458654
http://dx.doi.org/10.46497/ArchRheumatol.2020.7730
work_keys_str_mv AT pavlovdolijanovicslavica therelationshipbetweensup99msuptcpertechnetatehandperfusionscintigraphyandnailfoldcapillaroscopyinsystemicsclerosispatientsapilotstudy
AT petrovicnebojsa therelationshipbetweensup99msuptcpertechnetatehandperfusionscintigraphyandnailfoldcapillaroscopyinsystemicsclerosispatientsapilotstudy
AT vujasinovicstuparnada therelationshipbetweensup99msuptcpertechnetatehandperfusionscintigraphyandnailfoldcapillaroscopyinsystemicsclerosispatientsapilotstudy
AT damjanovnemanja therelationshipbetweensup99msuptcpertechnetatehandperfusionscintigraphyandnailfoldcapillaroscopyinsystemicsclerosispatientsapilotstudy
AT radunovicgoran therelationshipbetweensup99msuptcpertechnetatehandperfusionscintigraphyandnailfoldcapillaroscopyinsystemicsclerosispatientsapilotstudy
AT babicdragan therelationshipbetweensup99msuptcpertechnetatehandperfusionscintigraphyandnailfoldcapillaroscopyinsystemicsclerosispatientsapilotstudy
AT sobicsaranovicdragana therelationshipbetweensup99msuptcpertechnetatehandperfusionscintigraphyandnailfoldcapillaroscopyinsystemicsclerosispatientsapilotstudy
AT artikovera therelationshipbetweensup99msuptcpertechnetatehandperfusionscintigraphyandnailfoldcapillaroscopyinsystemicsclerosispatientsapilotstudy
AT pavlovdolijanovicslavica relationshipbetweensup99msuptcpertechnetatehandperfusionscintigraphyandnailfoldcapillaroscopyinsystemicsclerosispatientsapilotstudy
AT petrovicnebojsa relationshipbetweensup99msuptcpertechnetatehandperfusionscintigraphyandnailfoldcapillaroscopyinsystemicsclerosispatientsapilotstudy
AT vujasinovicstuparnada relationshipbetweensup99msuptcpertechnetatehandperfusionscintigraphyandnailfoldcapillaroscopyinsystemicsclerosispatientsapilotstudy
AT damjanovnemanja relationshipbetweensup99msuptcpertechnetatehandperfusionscintigraphyandnailfoldcapillaroscopyinsystemicsclerosispatientsapilotstudy
AT radunovicgoran relationshipbetweensup99msuptcpertechnetatehandperfusionscintigraphyandnailfoldcapillaroscopyinsystemicsclerosispatientsapilotstudy
AT babicdragan relationshipbetweensup99msuptcpertechnetatehandperfusionscintigraphyandnailfoldcapillaroscopyinsystemicsclerosispatientsapilotstudy
AT sobicsaranovicdragana relationshipbetweensup99msuptcpertechnetatehandperfusionscintigraphyandnailfoldcapillaroscopyinsystemicsclerosispatientsapilotstudy
AT artikovera relationshipbetweensup99msuptcpertechnetatehandperfusionscintigraphyandnailfoldcapillaroscopyinsystemicsclerosispatientsapilotstudy